Previous 10 | Next 10 |
2023-09-28 07:25:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re checking out the biggest pre-market stock movers on Friday with a dive into all of the latest market stories! Moving stocks this morning are clinical trials, new partnerships, ...
Moleculin Announces Completion of Enrollment in U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB107) PR Newswire – Data readouts expected before year end – Previously reported preliminary eff...
Moleculin Announces New Positive Independent Report of No Cardiotoxicity in Annamycin PR Newswire – Annamycin continues to demonstrate no evidence of cardiotoxicity to date, now in a total of 62 subjects across three of the Company's Annamycin clinical trials ...
2023-09-15 09:51:06 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nikola (NASDAQ: NKLA ) stock is a hot topic among traders on Friday as they go over the details of a new expansion in Canada . The big news here is Nikola signing an exp...
2023-09-15 09:23:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Volcon (NASDAQ: VLCN ) stock is falling on Friday after the electric power sports vehicles company revealed details of a public offering . According to a press release f...
2023-09-15 09:01:14 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Axcella Health (NASDAQ: AXLA ) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split . According to Axcella Healt...
2023-09-15 08:24:58 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Moleculin Biotech (NASDAQ: MBRX ) stock is on the move Friday after the clinical-stage pharmaceutical company provided an update to investors . According to a press rele...
Moleculin Announces Abstract Accepted for Poster Presentation at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting PR Newswire HOUSTON , Sept. 14, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a ...
2023-09-08 07:27:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a hot topic worth checking out on Friday with a look at today’s winners and losers! Moving stocks this morning are financial agreements, an earnings repor...
Moleculin to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire HOUSTON , Sept. 5, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a gr...
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML PR Newswire HOUSTON , July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfoli...
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial PR Newswire – 89% of CRc's were subjects with "poor prognosis" cytogenetics and/or mutations – Current median durability of response (mDOR) of CRc's = 6 months and in...